Name:
Manganese(II) bromide tetrahydrate 98%
Synonym:
Manganese dibromide tetrahydrate
CAS:
10031-20-6
Section 1 - Chemical Product
MSDS Name:Manganese(II) bromide tetrahydrate 98%
Synonym:Manganese dibromide tetrahydrate
Synonym:Manganese dibromide tetrahydrate
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | emsds | EINECS# |
| 10031-20-6 | Manganese(II) bromide tetrahydrate | 98 | unlisted |
| Hazard Symbols: None Listed. Risk Phrases: None Listed. |
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system effects and/or neurological effects. In high doses, manganese may increase anemia by interfering with iron absorption.
Inhalation:
May cause respiratory tract irritation. Chronic inhalation hazard.
The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May cause central nervous system effects and/or neurological effects. In high doses, manganese may increase anemia by interfering with iron absorption.
Inhalation:
May cause respiratory tract irritation. Chronic inhalation hazard.
The lowest exposure concentration of manganese at which early effects on the CNS and the lungs may occur is still unknown. However, once neurological signs are present, they tend to continue and worsen after exposure ends.
Chronic:
Chronic inhalation or ingestion may result in manganism characterized by neurological symptoms such as headache, apathy, and weakness of the legs, followed by psychosis and neurological symptoms similar to those of Parkinsons disease. May impair fertility. Other chronic effects from inhaling high amounts of manganese include an increased incidence of cough and bronchitis and susceptibility to infectious lung disease.
Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with impaired respiratory function or anemia may be at increased risk to the hazards associated with this substance.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with impaired respiratory function or anemia may be at increased risk to the hazards associated with this substance.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. This material in sufficient quantity and reduced particle size is capable of creating a dust explosion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. This material in sufficient quantity and reduced particle size is capable of creating a dust explosion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Use with adequate ventilation. Minimize dust generation and accumulation.
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from moisture.
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Use with adequate ventilation. Minimize dust generation and accumulation.
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from moisture.
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 10031-20-6: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) CAS# 13446-03-2: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 10031-20-6: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) CAS# 13446-03-2: United Kingdom, WEL - TWA: (listed as manganese, inorganic compounds): 0.5 mg/m3 TWA United Kingdom, WEL - STEL: (listed as manganese, inorganic compounds): 1.5 mg/m3 STEL United States OSHA: 5 mg/m3 Ceiling (as Mn) (listed under Mangan compounds, n.o.s.).
Belgium - TWA: (listed as manganese compounds, n.o.s.): 0.2 mg/m3 (as Mn) Japan: (listed as manganese compounds, n.o.s.): 0.3 mg/m3 OEL (ex organic compounds, as Mn) Malaysia: (listed as manganese, inorganic compounds): 0.2 mg/m3 T (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 3 mg/m3 STE (as Mn) Netherlands: (listed as manganese compounds, n.o.s.): 1 mg/m3 MAC Mn) Spain: (listed as manganese, inorganic compounds): 0.2 mg/m3 VLA- (as Mn) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHAs eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Crystals
Color: pink
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: Br2Mn.4H2O
Molecular Weight: 286.82
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
No significant incompatibilities identified with common materials and contaminants..
Hazardous Decomposition Products:
Hydrogen bromide, oxides of manganese.
Hazardous Polymerization: Has not been reported
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
No significant incompatibilities identified with common materials and contaminants..
Hazardous Decomposition Products:
Hydrogen bromide, oxides of manganese.
Hazardous Polymerization: Has not been reported
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 10031-20-6 unlisted.
CAS# 13446-03-2 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Manganese(II) bromide tetrahydrate - Not listed by ACGIH, IARC, or NTP.
Manganese bromide anhydrous - Not listed by ACGIH, IARC, or NTP.
CAS# 10031-20-6 unlisted.
CAS# 13446-03-2 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Manganese(II) bromide tetrahydrate - Not listed by ACGIH, IARC, or NTP.
Manganese bromide anhydrous - Not listed by ACGIH, IARC, or NTP.
Section 12 - ECOLOGICAL INFORMATION
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 10031-20-6: No information available.
CAS# 13446-03-2: No information available.
Canada
CAS# 13446-03-2 is listed on Canadas NDSL List.
CAS# 10031-20-6 is not listed on Canadas Ingredient Disclosure List.
CAS# 13446-03-2 is not listed on Canadas Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10031-20-6 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 13446-03-2 is listed on the TSCA inventory.
